Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Eckel

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Expert Opinion on Emerging Drugs|November 6, 2007
Emerging drugs for biliary cancerFlorian Eckel, Roland M Schmid
Chemotherapy|October 25, 2014
Chemotherapy and targeted therapy in advanced biliary tract carcinoma: a pooled analysis of clinical trialsFlorian Eckel, Roland M Schmid
Expert Opinion on Investigational Drugs|October 17, 2006
Pancreatic cancer: a review of recent advancesFlorian Eckel, Günter Schneider, Roland M Schmid
Cancer Investigation|March 21, 2002
Toxicity of a 24-hour infusion of gemcitabine in biliary tract and pancreatic cancer: a pilot studyFlorian Eckel, Christian Lersch, Gerald Assmann, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2011
Pancreatic and hepatobiliary cancersAndreas K Buck, Ken Herrmann, Florian Eckel, et al.
Cancer Investigation|November 25, 2003
Phase II trial of a 24-hour infusion of gemcitabine in previously untreated patients with advanced pancreatic adenocarcinomaFlorian Eckel, Renate Schmelz, Johannes Erdmann, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 19, 2020
Variplex™ test system fails to reliably detect SARS-CoV-2 directly from respiratory samples without RNA extractionFlorian Eckel, Franziska Küsters, Bernhard Drossel, et al.
Thrombosis and Haemostasis|August 28, 2007
Effect of low-molecular-weight heparin on survival in patients with advanced pancreatic adenocarcinomaStefan von Delius, Muhammed Ayvaz, Stefan Wagenpfeil, et al.
BMC Cancer|June 14, 2005
Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinomaStefan von Delius, Christian Lersch, Ewert Schulte-Frohlinde, et al.
Journal of Gastroenterology and Hepatology|August 11, 2007
Role of meal carbohydrate content for the imbalance of plasma amino acids in patients with liver cirrhosisEwert Schulte-Frohlinde, Stefan Wagenpfeil, Johanna Willis, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Expert Opinion on Emerging Drugs|November 6, 2007
Emerging drugs for biliary cancerFlorian Eckel, Roland M Schmid
Chemotherapy|October 25, 2014
Chemotherapy and targeted therapy in advanced biliary tract carcinoma: a pooled analysis of clinical trialsFlorian Eckel, Roland M Schmid
Expert Opinion on Investigational Drugs|October 17, 2006
Pancreatic cancer: a review of recent advancesFlorian Eckel, Günter Schneider, Roland M Schmid
Cancer Investigation|March 21, 2002
Toxicity of a 24-hour infusion of gemcitabine in biliary tract and pancreatic cancer: a pilot studyFlorian Eckel, Christian Lersch, Gerald Assmann, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2011
Pancreatic and hepatobiliary cancersAndreas K Buck, Ken Herrmann, Florian Eckel, et al.
Cancer Investigation|November 25, 2003
Phase II trial of a 24-hour infusion of gemcitabine in previously untreated patients with advanced pancreatic adenocarcinomaFlorian Eckel, Renate Schmelz, Johannes Erdmann, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 19, 2020
Variplex™ test system fails to reliably detect SARS-CoV-2 directly from respiratory samples without RNA extractionFlorian Eckel, Franziska Küsters, Bernhard Drossel, et al.
Thrombosis and Haemostasis|August 28, 2007
Effect of low-molecular-weight heparin on survival in patients with advanced pancreatic adenocarcinomaStefan von Delius, Muhammed Ayvaz, Stefan Wagenpfeil, et al.
BMC Cancer|June 14, 2005
Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinomaStefan von Delius, Christian Lersch, Ewert Schulte-Frohlinde, et al.
Journal of Gastroenterology and Hepatology|August 11, 2007
Role of meal carbohydrate content for the imbalance of plasma amino acids in patients with liver cirrhosisEwert Schulte-Frohlinde, Stefan Wagenpfeil, Johanna Willis, et al.
Pageof 3